Inhibition of ERK signaling for treatment of ERRα positive TNBC

Breast cancer is the second leading cause of cancer-related deaths in women and triple-negative breast cancer (TNBC), in particular, is an aggressive and highly metastatic type of breast cancer that does not respond to established targeted therapies and is associated with poor prognosis and worse su...

Descripción completa

Detalles Bibliográficos
Autores principales: Musheyev, David, Miller, Esther, Birnbaum, Natania, Miller, Elisheva, Erblich, Shoshana, Schuck, Alyssa, Alayev, Anya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171695/
https://www.ncbi.nlm.nih.gov/pubmed/37163498
http://dx.doi.org/10.1371/journal.pone.0283047

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171695/
https://www.ncbi.nlm.nih.gov/pubmed/37163498
http://dx.doi.org/10.1371/journal.pone.0283047

Ejemplares similares